
	※ 研究者情報全体を検索する場合は右端の「すべて」を選択して下さい。

1.	Yagi, M., Toshima, T., Amamoto, R., Do, Y., Hirai, H., Setoyama, D., Kang, D. & Uchiumi, T.,, Mitochondrial translation deficiency impairs NAD+-mediated lysosomal acidification, EMBO Journal, 40, 8, e105268., 2021.04.
2.	内海健, Mutation and functional analysis of ABCC2/multidrug resistance protein 2 in a Japanese patient with Dubin-Johnson syndrome., Hepatol. Research, 43, 569-575, 2013.02.
3.	Fukuda, T., Ashizuka, M., Nakamura, T., Shibahara,K., Maeda, K., Izumi, I., Kohno, K., Kuwano, M.,and Uchiumi,T.,, Characterization of 5'untranslated region of YB-1 mRNA and plausible regulation of translation., Nucleic Acid Res, 2004.01.
4.	Kuwano, M., Uchiumi, T., Hayakawa, H., Ono, M., Wada, M., Izumi, H., and Kohno, K, The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies., Cancer Sci, 10.1111/j.1349-7006.2003.tb01344.x, 94, 1, 9-14, 94: 9-14, 2003.01.
5.	Kohno K, Izumi H, Uchiumi T, Ashizuka M, and Kuwano M, The pleiotropic functions of the Y-box-binding protein, YB-1, Bioessays, 10.1002/bies.10300, 25, 7, 691-698, 25: 691-698, 2003.01.
6.	Ashizuka, M., Fukuda, T., Nakamura, T., Shirasuna, K., Iwai, K., Izumi, H., Kohno, K., Kuwano, M., and Uchiumi, T., Novel translational control through an iron-responsive element by interaction of multifunctional protein YB-1 and IRP2., Mol Cell Biol, 10.1128/MCB.22.18.6375-6383.2002, 22, 18, 6375-6383, 22: 6375-6383, 2002.01.
7.	Hashimoto K.,Uchiumi T., Konno T., Ebihara T., Nakamura T., Wada M., Sakisaka S., Maniwa F., Amachi T., Ueda K., and Kuwano M., Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome., Hepatology, 10.1053/jhep.2002.36368, 36, 5, 1236-1245, 36:1236-1245, 2002.01.
8.	Haga, S., Hinoshita, E., Ikezaki, K., Fukui, M., Scheffer, G. L., Uchiumi, T. and Kuwano, M., Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma., Jpn. J. Cancer Res, 92, 2, 211-219, 92: 211-219, 2001.01.
9.	Hinoshita, E., Taguchi, K., Inokuchi, A., Uchiumi, T., Kinukawa, N., Shimada, M., Tsuneyoshi, M., Sugimachi, K. and Kuwano, M., Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection., J. Hepatology, 10.1016/S0168-8278(01)00216-1, 35, 6, 765-773, 35,765-773, 2001.01.
10.	Inokuchi, A., Hinoshita, E., Wada, M., Iwamoto, Y., Kohno, K., Kuwano, M. and Uchiumi, T., Enhanced expression of Human Multidrug resistance protein 3 by bile salt in human enterocytes: a transcriptional control of plausible bile acid transporter., J. Biol. Chem., 10.1074/jbc.M104612200, 276, 50, 46822-46829, 276: 46822-46829, 2001.01.
11.	Hinoshita, E., Uchiumi, T., Taguchi, K., Kinukawa, N., Tsuneyoshi, M., Maehara, Y., Sugimachi, K. and Kuwano, M., Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas., Clin Cancer Res, 6, 6, 2401-2407, 6:2401-2407, 2000.01.
12.	Kawabe, T., Chen, Z., Wada, M., Uchiumi, T., Ono, M., Akiyama, S. and Kuwano, M., Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2)., FEBS Lett., 10.1016/S0014-5793(99)00979-5, 456, 2, 327-331, 456: 327-331, 1999.01.
13.	Tanaka,T., Uchiumi,T., Hinoshita,E., Inokuchi,A., Toh,S., Wada,M., Takano,H., Kohno,K., and Kuwano,M., The human multispecific resistance protein2 gene : functional characterization of 5'-flanking region and expression in hepatic cells., Hepatology, 30: 1507-1512, 1999.01.
14.	Uchiumi, T., Hinoshita, E., Haga, S., Nakamura, T., Tanaka, T., Toh, S., Furukawa, M., Kawabe, T., Wada, M., Kagotani, K., Okumura, K., Kohno, K., Akiyama, S. and Kuwano, M., Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport., Biochem. Biophys. Res. Commun, 10.1006/bbrc.1998.9546, 252, 1, 103-110, 252: 103-110, 1998.01.
15.	Uchiumi, T., Longo, D. and Ferris, D, Cell cycle regulation of PLK promoter., J. Bio. Chem, 272,9166-9174, 1997.01.

1.	内海健, ミトコンドリアタンパクp32の脳特異的ノックアウトマウスの分子基盤と新規診断マーカーの探索, 第55回日本臨床化学会, 2015.10.
2.	内海健, ミトコンドリア蛋白質p32のRAS依存性発ガン形質転換への関与, 第７４回日本癌学会 , 2015.10.
3.	内海健, KANG DONGCHON, 前立腺がんにおけるmtCK(mitochondria creatine kinase)発現様式とメタボローム, 第４６回　日本臨床検査自動化学会, 2014.10.
4.	内海健, ミトコンドリア蛋白質p32のRAS依存性発ガン形質転換への関与, 第６１回　日本臨床検査医学会　　, 2014.11.
5.	内海健, 八木美佳子, KANG DONGCHON, 心筋特異的p32ノックアウトマウスは拡張型心筋症を発症するがmtUPR, autophagyを誘導し生存する, 第１４回　日本ミトコンドリア学会, 2014.12.
6.	内海健, KANG DONGCHON, 八木美佳子, Cardiomyocyte Specific Deletion of p32/C1qbp Causes Mitochondrial Cardiomyopathy, EuroMit, 2014.06.
7.	内海健, p32/gC1qR is indispensable for fetal development and mitochondrial translation: importance of its RNA binding ability, ミトコンドリア学会, 2013.11.
8.	Takeshi Uchiumi , Dongchon Kang, ERAL1 is localized in mitochondria matrix and knockdown of ERAL1 leads to cell cycle arrest and growth retardation, 第３１回日本分子生物学会, 2008.12.
9.	Takeshi Uchiumi, Tetsuro Wakasugi, Hiroto Izumi, Kimitoshi Kohno , ZNF143 interacts with p73 and involves in cisplatin resistance, 0th IUBMB International Congress of Biochemistry and Molecular Biology, 2006.06.

年度	外国語雑誌査読論文数	合計
2018年度	2	2
2015年度	2	2
2014年度	0	0
2013年度	1	1
2012年度	3	3
2011年度	2	2
2010年度	3	3
2009年度	3	3
2008年度	1	1
2007年度	1	1
2006年度	1	1

九大関連コンテンツ